DYAI - Dyadic International Inc., DE
IEX Last Trade
1.35
-0.020 -1.481%
Share volume: 32,605
Last Updated: Fri 30 Aug 2024 09:56:40 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.37
-0.02
-1.46%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-10 | 2023-03-29 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-28 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 17.223 M | 15.219 M | 13.713 M | 12.812 M | 11.075 M | 9.256 M | 8.219 M | 12.681 M | |
| Current Assets | 16.933 M | 14.928 M | 13.422 M | 12.805 M | 11.069 M | 9.088 M | 8.067 M | 12.541 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 104.831 K | 448.208 K | 392.236 K | 284.597 K | 136.152 K | 484.188 K | 327.775 K | 242.131 K | |
| Short Term Investments | 104.831 K | 448.208 K | 392.236 K | 284.597 K | 136.152 K | 484.188 K | 327.775 K | 242.131 K | |
| Total Receivables | 1.188 M | 279.241 K | 388.286 K | 784.176 K | 803.650 K | 427.700 K | 476.242 K | 261.365 K | |
| Current Cash | 15.640 M | 14.201 M | 12.642 M | 11.737 M | 10.129 M | 8.176 M | 7.263 M | 12.038 M | |
| Total Non-current Assets | 290.733 K | 290.712 K | 290.754 K | 6.065 K | 5.822 K | 167.698 K | 151.901 K | 139.954 K | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 6.024 K | 6.003 K | 6.045 K | 6.065 K | 5.822 K | 167.698 K | 151.901 K | 139.954 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 17.223 M | 15.219 M | 13.713 M | 12.812 M | 11.075 M | 9.256 M | 8.219 M | 12.681 M | |
| Total liabilities | 3.662 M | 2.607 M | 2.625 M | 2.007 M | 2.089 M | 1.603 M | 2.341 M | 8.165 M | |
| Total current liabilities | 3.397 M | 2.387 M | 2.449 M | 1.875 M | 2.001 M | 1.457 M | 2.252 M | 2.262 M | |
| Accounts Payable | 1.095 M | 777.238 K | 1.276 M | 770.371 K | 905.876 K | 600.148 K | 656.445 K | 661.243 K | |
| Other liabilities | 264.706 K | 220.588 K | 176.471 K | 132.353 K | 88.235 K | 44.118 K | 88.870 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 46.599 K | 0.000 | 49.551 K | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 101.567 K | 0.000 | 5.903 M | |
| Other liabilities | 264.706 K | 220.588 K | 176.471 K | 132.353 K | 88.235 K | 44.118 K | 88.870 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 13.561 M | 12.612 M | 11.088 M | 10.804 M | 8.985 M | 7.653 M | 5.879 M | 4.516 M | |
| Common stock | 28.264 M | 28.392 M | 28.551 M | 28.761 M | 28.811 M | 28.811 M | 28.812 M | 28.828 M | |
| Retained earnings | -69.526 M | -71.335 M | -73.482 M | -74.438 M | -76.591 M | -78.206 M | -80.277 M | -82.287 M |